Lymphoid cells and the microenvironment interact to define health and immunity of the host
Microbiota, lymphoid cells and “stromal” cells develop a crosstalk that allows maintaining homeostasis, organize defense, and resolve inflammation to restore tissue integrity. Deregulation of this crosstalk prolongs inflammation or prevents the healing process, resulting in chronic inflammatory pathologies. Our previous work has led us to define central actors among pro-inflammatory lymphoid and stromal cells (in collaboration with the team of Lucie Peduto, https://research.pasteur.fr/en/team/group-lucie-peduto/), and to identify components of the symbiotic microbiota that efficiently modulate immunity.
Immunity comes into mainly 3 types of effector responses directed against intracellular microbes and tumors, large parasites or extracellular microbes. These responses are orchestrated by dendritic cells (DCs) and regulated by T (helper) Th1, Th2 and Th17 cells. Three types of ILCs have recently been described that mimic the activity of Th cells and that are termed ILC1, ILC2 and ILC3. As ILCs act promptly upon infection and injury, and express large amounts of effector cytokines, it is expected that they play an important role early in the regulation of immune responses. To directly explore this hypothesis, we have generated a panel of transgenic mice that allow for the timed ablation of each individual subset of ILCs, without damage to other immune cells. As ILCs are also involved in inflammatory pathology in response to chronic injury and metabolic stress, we explore how ILCs can be manipulated to restore normal immune functions, and extend our findings to human disease.
The development, homeostasis and pathology of the host are influenced at many levels by the symbiotic microbiota. In particular, we have shown how microbiota regulates the activity of RORgt+ ILCs and T cells, in collaboration with the team of Ivo Boneca, https://research.pasteur.fr/en/team/biology-and-genetics-of-bacterial-cell-wall/). Large projects around the world aim at dissecting the impact of microbiota on human health. We focus on the study of specific bacterial compounds shown to affect the activity of ILCs, such as peptidoglycans recognized by the Nod1 and Nod2 innate receptors, and polysaccharides recognized by TLRs and MHC molecules. We explore the effect of these metabolites on the regulation of immune responses, as well as on the host nervous system that modulates immunity. We also explore the regulation of the microbiota composition and activity by RORgt+ pro-inflammatory cells and the different subsets of ILCs during homeostasis and inflammation. These studies are performed in collaboration with clinical and industrial partners interested in the development of health-efficient probiotics.
The integrative dialogue between the immune system and the nervous systems.The nervous system establishes an extensive network of sensors that not only inform the central nervous sytem of the state of the organism and perturbations to it, but also coordinates the actions of different systems. Both the immune and the nervous sytems integrate information and react to maintain homeostatis of the whole. We develop projects, in collaboration with the team of Pierre-Marie Lledo, https://research.pasteur.fr/en/team/perception-and-memory/), that aim to decipher the regulation of the immune system by the nervous system using cutting-edge neuron manipulation techniques, and in reverse, to measure the activity of the nervous system upon perturbations of the immune system, during the steady state interaction with the symbiotic microbiota, during infection and inflammation.
Quote of the month: I never loose. I either win or learn. Nelson Mandela